The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
Overview
Molecular Biology
Affiliations
Despite intensive research, malignant brain tumors are among the most difficult to treat due to high resistance to conventional therapeutic approaches. High-grade malignant gliomas, including glioblastoma and anaplastic astrocytoma, are among the most devastating and rapidly growing cancers. Despite the ability of standard treatment agents to achieve therapeutic concentrations in the brain, malignant gliomas are often resistant to alkylating agents. Resveratrol is a plant polyphenol occurring in nuts, berries, grapes, and red wine. Resveratrol crosses the blood‒brain barrier and may influence the central nervous system. Moreover, it influences the enzyme isocitrate dehydrogenase and, more importantly, the resistance to standard treatment via various mechanisms, such as O6-methylguanine methyltransferase. This review summarizes the anticancer effects of resveratrol in various types of brain cancer. Several in vitro and in vivo studies have presented promising results; however, further clinical research is necessary to prove the therapeutic efficacy of resveratrol in brain cancer treatment.
The Potential Application of Resveratrol and Its Derivatives in Central Nervous System Tumors.
Nowacka A, Sniegocka M, Smuczynski W, Liss S, Ziolkowska E, Bozilow D Int J Mol Sci. 2025; 25(24.
PMID: 39769099 PMC: 11728356. DOI: 10.3390/ijms252413338.
Nrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management.
Dewanjee S, Bhattacharya H, Bhattacharyya C, Chakraborty P, Fleishman J, Alexiou A Cell Commun Signal. 2024; 22(1):497.
PMID: 39407193 PMC: 11476647. DOI: 10.1186/s12964-024-01878-2.
Resveratrol Inhibits Nasopharyngeal Carcinoma (NPC) by Targeting the MAPK Signaling Pathway.
Yi Y, Zhou B, Man T, Xu Z, Tang H, Li J Anticancer Agents Med Chem. 2024; 24(16):1207-1219.
PMID: 38988166 DOI: 10.2174/0118715206319761240705115109.
Polyphenols Modulate the miRNAs Expression that Involved in Glioblastoma.
Rezaie M, Nasehi M, Shimia M, Ebrahimnezhad M, Yousefi B, Majidinia M Mini Rev Med Chem. 2024; 24(21):1953-1969.
PMID: 38639278 DOI: 10.2174/0113895575304605240408105201.
Yahayo W, Pongkittiphan V, Supabphol R, Saiyudthong S Asian Pac J Cancer Prev. 2024; 25(3):939-949.
PMID: 38546076 PMC: 11152376. DOI: 10.31557/APJCP.2024.25.3.939.